Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.

This early-stage trial tests an experimental mRNA vaccine called YKYY025 designed to protect against respiratory syncytial virus (RSV). Healthy adults aged 18 and older receive a single injection of either the vaccine or a placebo. Researchers monitor safety, side effects, and im…

This early-stage trial is testing whether a single injection of an experimental drug called YKYY033 is safe and tolerable in healthy adults aged 18 to 55. The study will also measure how the drug moves through the body and how it affects a clotting factor. If successful, YKYY033 …

This early-phase trial tests a new drug called YKYY031 in 76 people with advanced solid tumors (like colorectal or pancreatic cancer) that have stopped responding to standard treatments. The main goals are to check safety, find the right dose, and get a first look at whether the …